-
D649405-10mg
Dovramilast (C09-1126-101)
Price: $730.82List Price: $812.03Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor and can reduce the inflammatory response and improves Isoniazid (INH)-mediated bacillary clearance from the lungs. Dovramilast, as an adjunct, is used for the research -
D649405-25mg
Dovramilast (C09-1126-102)
Price: $1,399.74List Price: $1,555.27Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor and can reduce the inflammatory response and improves Isoniazid (INH)-mediated bacillary clearance from the lungs. Dovramilast, as an adjunct, is used for the research -
D649405-5mg
Dovramilast (C09-1126-103)
Price: $492.33List Price: $547.03Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor and can reduce the inflammatory response and improves Isoniazid (INH)-mediated bacillary clearance from the lungs. Dovramilast, as an adjunct, is used for the research -
D423194-1ml
Doxapram (C09-0862-442)
Price: $312.66List Price: $347.40a central respiratory stimulant. -
Y0000208
DOXAPRAM IMPURITY B EUROPEAN PHARMACOPOEIA (EP) REFERENCE STANDARD
Price: $421.27List Price: $468.07General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the -
1225022-25MG
DOXAPRAM RELATED COMPOUND B UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,463.54List Price: $2,737.26This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the -
1225420-20MG
DOXAZOSIN RELATED COMPOUND A UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,679.32List Price: $2,977.02This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1225441-20MG
DOXAZOSIN RELATED COMPOUND B UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,679.32List Price: $2,977.02This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1225452-20MG
DOXAZOSIN RELATED COMPOUND C UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,733.27List Price: $3,036.96This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1225474-20MG
DOXAZOSIN RELATED COMPOUND E UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,679.32List Price: $2,977.02This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1225485-15MG
DOXAZOSIN RELATED COMPOUND F UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,355.64List Price: $2,617.38This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
F654719-1ml
Faropenem daloxate (C09-1133-958)
Price: $298.45List Price: $331.61Faropenem daloxate is the first oral penem in a new class of beta-lactam antibiotics .IC50 Value:Target: AntibacterialFaropenem daloxate is useful for penem and antibiotics . Faropenem medoxomil has excellent in vitro activity against Streptococcus